Naproxen Prices Trend and Forecast

North America

The Naproxen Prices started in the first quarter of 2023 on a bullish note and ended at a sturdy rate. This price trend was attributed to increased domestic orders from end-user pharmaceutical sectors. Also, during January 2023, traders encountered the costliest import from China as Yuan gained against the US dollar, appreciating nearly 3% in January alone. Moreover, until the mid of the first quarter, consumer sentiments remained on the upper side, and ease in trade disruption altogether supported the positive market trend for Naproxen API in North America. Towards the termination of this quarter, the prices of Naproxen increased consistently and were recorded at USD 41800/MT in the United States.

APAC

Throughout the APAC region, particularly in China, the prices of Naproxen remain on the upper side trend during the first quarter of 2023. A significant increase in domestic and international inquiries and lessened stockpiles among the market participants. Moreover, the government of China additionally stated that the February rise in PMI showed continued improvement in the climate for production and industry, noting that the total volume of activity "inclined significantly" as the customer interest raised during this month along with the newer orders from the international market.  With this, the prices of Naproxen went in the upward direction until the end of the first quarter with a settlement at USD 40988/MT in China.

Europe

In the first quarter of 2023, the prices of Naproxen API commenced on the positive side during the month of January and continued to maintain a similar trend until mid of Q1-2023 but ended on a bearish note. Until February, the prices went in the upward direction due to certain factors, including a rise in local demand, limited inventories, ease of trade activity, and a decline in freight charges. Additionally, German consumer prices rose more than expected, which progressively boosted the overall market trend of Naproxen in the European region. However, towards the termination of the first quarter, the prices of Naproxen went down drastically and were settled at USD 41250/MT in Germany.

ChemAnalyst addresses the key problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make smart choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls in an efficient and agile manner. Timeliness and accuracy of data has been the core competency of ChemAnalyst, benefitting domestic as well as global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.